Cafaminol
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Trade names | Rhinetten, Rhinoptil |
| Other names | Methylcoffanolamine; 8-[(2-Hydroxyethyl)(methyl)amino]caffeine |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.045.795 |
| Chemical and physical data | |
| Formula | C11H17N5O3 |
| Molar mass | 267.289 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Cafaminol (brand names Rhinetten, Rhinoptil), also known as methylcoffanolamine, is a vasoconstrictor and anticatarrhal of the methylxanthine family related to caffeine which is used as a nasal decongestant in Germany. It was introduced in 1974 and was still in use as of 2000.
|
Decongestants and other nasal preparations (R01)
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Topical |
|
||||||||||
| Systemic use: Sympathomimetics |
|||||||||||
| |||||||||||